Therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles in SARS‐CoV‐2 and H1N1 influenza‐induced acute lung injury

Documenti analoghi

• Y‐box binding protein 1 in small extracellular vesicles reduces mesenchymal stem cell differentiation to osteoblasts—implications for acute myeloid leukaemia
  di: Venkatesh Kumar Chetty, et al.
  Pubblicazione: (2024)
• Hypoxia and TNF‐alpha modulate extracellular vesicle release from human induced pluripotent stem cell‐derived cardiomyocytes
  di: Margarida Viola, et al.
  Pubblicazione: (2024)
• A new subtype of artificial cell‐derived vesicles from dental pulp stem cells with the bioequivalence and higher acquisition efficiency compared to extracellular vesicles
  di: Xingxiang Duan, et al.
  Pubblicazione: (2024)
• Fused extracellular vesicles from M2 macrophages and human umbilical cord mesenchymal stem cells for the targeted regulation of macrophage pyroptosis in periprosthetic osteolysis
  di: Qimeng Liu, et al.
  Pubblicazione: (2024)
• Evaluation of unmodified human cell‐derived extracellular vesicle mitochondrial deoxyribonucleic acid‐based biodistribution in rodents
  di: Young‐Woo Cho, et al.
  Pubblicazione: (2024)